Three questions — three instruments

Gut diagnostics is not a single test. It is a battery of functional analyses answering specific clinical questions. GI Effects®, the SIBO breath test and Organix® measure fundamentally different things in fundamentally different parts of the gastrointestinal tract — and with fundamentally different methodology.

The clinical error occurs when the patient or clinician assumes that a negative result from one of these tests rules out gut pathology. It does not. It rules out only the specific question that test was designed to answer.

Primary clinical question per test
GI Effects®What is in the gut and how is it functioning?
SIBO breath testIs there bacterial overgrowth in the small intestine?
Organix®Is gut dysbiosis affecting the body systemically?

GI Effects® — the complete large intestine profile

GI Effects® Comprehensive Stool Profile combines several methods to report selected microorganisms and markers related to digestion, inflammation and the gut environment. The exact content depends on the profile ordered.

The profile reports selected microorganisms, digestive markers such as pancreatic elastase and faecal fat, inflammation-related markers such as calprotectin, and other stool markers. Zonulin-family peptides are indirect markers with method limitations; they do not independently confirm intestinal permeability.

Indicated when

  • IBS-like symptoms (bloating, diarrhoea, constipation, altered bowel habits)
  • Suspected dysbiosis without a specified cause
  • Autoimmune conditions with intestinal component
  • Chronic low-grade inflammation without identified source
  • Follow-up of gut health treatment protocols
  • Hormonal imbalances (beta-glucuronidase affects oestrogen metabolism)

SIBO breath test — the small intestine's bacterial picture

Small intestinal bacterial overgrowth (SIBO) concerns an increased number or altered composition of bacteria in the small intestine. Symptoms may include bloating, pain and altered bowel habits. Assessment considers other possible explanations too.

The breath test measures hydrogen and methane at specified intervals after a test substrate. The pattern can contribute to assessment of suspected SIBO or intestinal methanogen overgrowth (IMO). Methane is associated with constipation. Interpretation depends on the protocol, preparation and clinical picture.

Indicated when

  • Predominant bloating occurring rapidly after meals (small intestine, not large)
  • Previous SIBO diagnosis to be confirmed or excluded
  • Conditions associated with motility disorders (hypothyroidism, diabetes, scleroderma)
  • Recurrent gut symptoms despite elimination protocols
  • Malabsorption without explained aetiology
  • Patients with constipation-dominant IBS (methane profile)
Clinical observation

The breath test and GI Effects answer different questions. The first reports gas patterns after a substrate; the second reports stool markers. We choose tests according to your symptoms and the question that could affect your care.

Organix® — the systemic signature of dysbiosis

Organix® Comprehensive Profile (urinary organic acids) analyses metabolites in urine produced by the metabolism of gut bacteria and fungi. Unlike GI Effects, which identifies organisms in stool, Organix measures what these organisms produce and how their metabolites affect host biochemistry.

The test detects arabinose (Candida marker), D-lactate (sign of bacterial fermentation), hydroxyphenylacetic acid and hydroxyphenyllactic acid (catabolic markers associated with dysbiosis), along with markers for mitochondrial function, B-vitamin status and neurotransmitter metabolism.

The clinically unique aspect of Organix is that it links gut dysbiosis to systemic biochemical consequences. A patient with normal gut flora in stool may have an Organix profile showing that residual metabolites from yeast or bacterial overgrowth are disrupting central metabolic pathways.

Indicated when

  • Chronic fatigue and brain fog without clear gut cause in GI Effects
  • Suspected Candida overgrowth with systemic impact
  • Skin manifestations that may have a dysbiotic gut component
  • Psychiatric symptoms (depression, anxiety) with suspected gut-brain axis involvement
  • Recurrent yeast infections
  • Complementing GI Effects when systemic impact is unclear

Decision matrix — which test, when

Clinical question GI Effects® SIBO test Organix®
Large intestine microbiome ✓ Primary — —
Small intestine bacteria — ✓ Primary Indirect
Fungal overgrowth (Candida) Culture — ✓ Primary
Gut barrier (zonulin) ✓ — —
Gut inflammation ✓ Calprotectin — —
Systemic metabolic impact — — ✓ Primary
Digestive capacity ✓ Elastase, fat — Indirect
Neurotransmitter impact — — ✓

Clinical sequencing — when all three are needed

In complex cases involving IBS, chronic fatigue, autoimmunity or psychiatric symptoms, it is rational to order all three tests in parallel. They do not answer overlapping questions — they answer three distinctly different layers of the gut picture.

We use GCR to organise relevant findings and prioritise follow-up. Stool markers, breath-test curves and urine metabolites contribute different information, each interpreted with your symptoms and medical history.

A negative GI Effects result is routinely used to rule out gut problems. It is a logic error. GI Effects rules out large intestine pathology — not small intestinal overgrowth and not systemic dysbiotic metabolic impact.

Plain language summary
Which gut test is right for you?

If you have bloating, altered bowel habits and general digestive discomfort, GI Effects® is the broadest starting tool — it gives a complete picture of what is actually in the gut and how it is functioning.

The timing of bloating, bowel habits, previous treatment and other symptoms help guide test selection. At a consultation, we review which question matters and whether a breath test or another investigation is appropriate.

If you have symptoms like brain fog, skin problems or fatigue that do not seem connected to an obvious gut cause — Organix® reveals whether gut bacteria and fungi are affecting your metabolism at the systemic level.